Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

FLJ13611 Inhibitors

FLJ13611 inhibitors constitute a chemical class designed to interact with and impede the activity of the protein associated with the FLJ13611 gene, which is a part of the human genome with an as-yet incompletely understood biological function. These inhibitors are molecules that specifically bind to the FLJ13611 protein, targeting its active site or other critical regions necessary for its activity, and reduce its function by obstructing its normal biological mechanisms. The inhibition may occur through various modes of action, such as competitive inhibition, where the inhibitor molecules compete with the natural substrates or ligands for binding sites, or non-competitive inhibition, where the binding of the inhibitor alters the protein's conformation, rendering it less active or inactive.

The molecular architecture of FLJ13611 inhibitors is diverse, as they are tailored to fit into the binding pockets or adhere to the surface of the FLJ13611 protein with high specificity. This structural diversity ensures that these inhibitors can effectively interact with the protein in different ways, leading to a reduction in its activity. The design of FLJ13611 inhibitors takes into account the size, shape, and electronic characteristics of the target site on the protein, aiming to achieve a strong and specific interaction. These interactions may involve a range of non-covalent forces, such as hydrogen bonds, hydrophobic interactions, and van der Waals forces, which collectively contribute to the binding affinity of the inhibitor. The selectivity of FLJ13611 inhibitors is crucial to their function, as it allows them to selectively interact with the FLJ13611 protein without affecting other proteins with similar structures or functions.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Nutlin-3

548472-68-0sc-45061
sc-45061A
sc-45061B
1 mg
5 mg
25 mg
$56.00
$212.00
$764.00
24
(1)

Disrupts protein-protein interactions which can influence ZNF770's protein binding capabilities.

2-Aminopurine

452-06-2sc-287828
sc-287828A
100 mg
250 mg
$118.00
$185.00
(0)

Alters protein-protein and protein-DNA interactions which can affect ZNF770 indirectly.

Gallotannin

1401-55-4sc-202619
sc-202619A
sc-202619B
sc-202619C
sc-202619D
sc-202619E
sc-202619F
1 g
10 g
100 g
250 g
1 kg
2.5 kg
5 kg
$25.00
$36.00
$66.00
$76.00
$229.00
$525.00
$964.00
12
(1)

Known to inhibit protein-protein interactions, potentially influencing ZNF770's function.

STO-609

52029-86-4sc-507444
5 mg
$140.00
(0)

Inhibits the CAMKK beta-AMPK pathway, potentially disrupting processes related to ZNF770.

Ibrutinib

936563-96-1sc-483194
10 mg
$153.00
5
(0)

Targets kinases modulating various protein-protein interactions, potentially affecting ZNF770 indirectly.

Mdivi-1

338967-87-6sc-215291
sc-215291B
sc-215291A
sc-215291C
5 mg
10 mg
25 mg
50 mg
$66.00
$124.00
$246.00
$456.00
13
(2)

Impairs protein-protein interactions related to mitochondrial fission, potentially affecting cellular processes where ZNF770 is involved.

Suramin sodium

129-46-4sc-507209
sc-507209F
sc-507209A
sc-507209B
sc-507209C
sc-507209D
sc-507209E
50 mg
100 mg
250 mg
1 g
10 g
25 g
50 g
$149.00
$210.00
$714.00
$2550.00
$10750.00
$21410.00
$40290.00
5
(1)

Affects various protein-protein interactions, offering potential indirect effects on ZNF770's functionality.

Chelerythrine chloride

3895-92-9sc-3547
sc-3547A
5 mg
25 mg
$88.00
$311.00
17
(1)

Inhibits protein kinase C, affecting downstream protein-protein interactions, potentially influencing ZNF770 indirectly.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$30.00
$52.00
$122.00
$367.00
25
(3)

Impairs protein transport, potentially affecting the localization and interactions of ZNF770.

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$38.00
$58.00
$102.00
$202.00
8
(1)

Targets Hsp90, disrupting client protein interactions, potentially affecting proteins associated with ZNF770.